GILUPI Media
Downloads, Information & important Links
MEDIA
Current news, Videos, Brochures, Press Releases, Literature References and various downloadable Material are provide here in our media area. Find extensive information ...
Brochures & Information
Allgemeine Infobroschüre - Fachpersonal Deutsch
"In vivo Isolierung von zirkulierenden Tumorzellen" Individuelle Diagnostik für innovative Behandlung
Download BroschüreGeneral Information Booklet - Professionals English
"In vivo Isolation of circulating tumor cells" Advancing diagnostics for precision medicine.
Download BookletAllgemeine Infobroschüre - Patienten Deutsch
"Anreicherung von zirkulierenden Tumorzellen aus dem Blutkreislauf" Individuelle Diagnostik für innovative Behandlung von Tumorerkrankungen
DOWNLOAD BROSCHÜREPublications
April, 2024 - A real-world comparison of circulating tumor cells in breast cancer from China: Novel device, CTC counts and its overall survival
F. Li et al., DOI: 10.1016/j.heliyon.2024.e29217
Link PublikationMarch, 2023 - Baseline CTC Count as a Predictor of Long-Term Outcomes in High-Risk Prostate Cancer
W. A. Cieślikowski et al., DOI: 10.3390/jpm13040608
Link PublikationFebruary, 2022 - Strategies for Isolating and Propagating Circulating Tumor Cells in Men with Metastatic Prostate Cancer
G. Theil et al., DOI: 10.3390/diagnostics12020497
Link PublikationJanuary, 2022 - Potential Use of CTCs as Biomarkers in Renal Cancer Patients
J. Bialek et al., DOI: 10.3390/life12010089
Link PublikationJuly, 2021 - Association of Circulating Tumor Cells with Inflammatory and Biomarkers in the Blood of Patients with Metastatic Castration-Resistant Prostate Cancer
G. Theil et al., DOI:10.3390/life11070664
Link PublikationJun, 2021 - Circulating Tumor Cell Persistence Associates with LongTerm Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
I. J. Guldvik et al., DOI: 10.3390/jpm11070605
Link PublikationMay, 2021 - In vivo isolation of circulating tumor cells in patients with different stages of prostate cancer
G. Theil et al., DOI: 10.3892/ol.2021.12618
Link PublikationJanuary, 2021 - Recognition of the organ-specific mutations in metastatic breast cancer by circulating tumor cells isolated in vivo
S. Li et al., DOI: 10.4149/neo_2020_200317N275
Link PublikationMay, 2020 - A Multi-Analyte Approach for Improved Sensitivity of Liquid Biopsies in Prostate Cancer
L. Hoffmann et al., DOI: 10.3390/cancers12082247
Link PublikationJune, 2020 - In Vivo Enrichment and Elimination of Circulating Tumor Cells by Using a Black Phosphorus and Antibody Functionalized Intravenous Catheter
D. Wang et al., DOI: 10.1002/advs.202000940
Link PublikationJune, 2020 - In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict Prognosis in Patients with Metastatic Breast Cancer
N. Xie et al., DOI: 10.1007/s12253-020-00847-7
Link PublikationPress Releases
March, 18, 2021 - GILUPI and SCIENION announce Collaboration...
...for for the Development of Single-Cell CTC Analysis. Potsdam and Berlin, Germany: GILUPI GmbH and SCIENION AG today announced that the companies intend to intensify their collaboration in the field of single circulating tumor cell (CTC) analysis.
Download PRFebruary, 23, 2021 - GILUPI CellCollector® Technology Selected...
... for Application in Phase I TENDU Study. The GILUPI CellCollector® is the technology of choice for the analysis of circulating tumor cells (CTCs) in a clinical trial just recently started and announced by Norwegian company Ultimovacs ASA.
Download PRSeptember, 19, 2019 - Attendance and Exhibition at the ACTC Conference 2019
The company is a sponsor of the 4th ACTC “Liquid Biopsy: Latest Advances and Future Challenges” meeting. The conference is held in Corfu, Greece from October 2nd to 5th 2019.
Download PRAugust, 12, 2019 - New Publications from multicenter prostate cancer study - TRANSCAN
The blood of cancer patients contains different types of tumor-derived materials that are susceptible to a downstream analysis for example in order to predict therapy response.
Download PRJanuary, 10, 2019 - GILUPI participates in Consortium “European Liquid Biopsies Academy” – ELBA
The research program and educational curriculum of the European Liquid Biopsy Academy - ELBA[1] , a MSCA ITN funded project (GA 765492), educates 15 early stage researchers in a range of applications and disease areas surrounding liquid biopsy
Download PR
